The Cologuard Plus test is being offered as an in-network service to eligible Humana Medicare Advantage members.

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded ...

Humana also used a tactic to deter physicians from using Cologuard to screen their patients; the company circulated fliers among their in-network providers in Kentucky that said “Cologuard is ...

Madison, Wis.-based Exact Sciences Corp. agreed to a contract with Louisville, Ky.-based Humana to cover its Cologuard colon cancer screening test as an in-network service.

Starting January 1, 2017, Humana will cover Cologuard, the FDA-approved multi-target stool DNA test for noninvasive colorectal cancer screening, as an in-network service for its members, most of ...

2. Humana joins several other insurers nationwide that cover the test. Cologuard is now available to more than 153 million members. 3. Since Cologuard’s inclusion as an A-rated service in the ...

Louisville, Ky.-based Humana contracted with Madison, Wis.-based Exact Sciences Corp. to cover Cologuard — a colon cancer test — as an in-network service for its members. Effective Jan. 1 ...

Madison, Wis.-based Exact Sciences, which provides the non-invasive test for colorectal cancer Cologuard, is suing Humana for refusing to pay for thousands of screenings totaling $800,000 in ...

Cologuard Plus is a more sensitive version of the original Cologuard that was first approved in 2014. The test is for people 45 and older who are at average risk of colorectal cancer, meaning ...

A Humana spokesperson told Benzinga exclusively that starting January 1, 2017, "Humana's Commercial members may be eligible under their plan for the Cologuard test once every three years.

SHREVEPORT, La. -- No one likes to get a colonoscopy, but it's an important tool in the fight against colon cancer. There is an easier way: Cologuard is a non-invasive, effective, and affordable ...

Here’s the thing, though: Exact Sciences says Cologuard isn’t an exact science. In a full-page ad that ran this week in the New York Times, the company said that while the test can detect 92% ...